comparemela.com

Latest Breaking News On - Sciad communications ltd - Page 4 : comparemela.com

ReViral Ltd : Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates

Proposed acquisition strengthens Pfizer's capabilities in infectious disease research and development with a complementary strategy to help improve patient outcomes through treatment for respiratory

Easyfairs opens registration for new Connect in Pharma event

New Geneva-based event is set to bring together innovators in pharma packaging, devices and processing.London, United Kingdom, 22nd March 2022 / Sciad Newswire / Leading international events company Easyfairs today opens online registration for Connect in Pharma, the new event for the European pharma and biopharma c.

NanoSyrinx appoints R&D industry leader Dr Marie McAvoy as Chief Scientific Officer

Coventry, United Kingdom, 10th March 2022 / Sciad Newswire / NanoSyrinx, a biotech company using synthetic biology approaches to develop a new modality for the targeted intracellular delivery of biologic therapeutics, has strengthened its management team with the appointment of Dr Marie McAvoy as its Chief Scientifi.

New PROFINET-enabled pumps from Watson-Marlow enable seamless integration of fluid delivery up to en

Falmouth, UK, 18th February 2022 / Sciad Newswire / Watson-Marlow Fluid Technology Group (WMFTG) is extending its industrial Ethernet control offer by making PROFINET available on its 530, 630 and 730 series of cased peristaltic pumps. This additional communication capability allows customers to access fast, accurat.

New PROFINET-enabled pumps from Watson-Marlow enable seamless integration of fluid delivery up to en

530, 630 and 730 pumps are now PROFINET-enabledIndustrial Ethernet provides real time process information for enhanced productivityNetwork dosing and dispensing features avoid network lagsReduce system cost and complexity by using the pump as a gateway to sensor dataFalmouth, UK, 16th February 2022 / Sciad Newswire.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.